Sevi Faria
Sevi completed her Bachelor's and Master's degrees in Biochemistry at Goethe University Frankfurt, Germany. Her Bachelor's thesis, under the supervision of Prof. Dr. Zoltán Ivics, was conducted at the Paul-Ehrlich-Institute, where she applied CRISPR-Cas technology to introduce mutations in the snRNP70 gene in human cells. She completed her Master's thesis under Prof. Dr. Robert Tampé at Goethe University, where she investigated T-cell receptor clustering and T-cell activation on microstructured matrices.
Sevi joined the Stolz lab in September 2024 as a research assistant, where she supports the PROXIDRUGS.2 team in conducting research, and assisting with various molecular biology and biochemistry techniques.
Research Assistant